The treatment of honeymoon impotence by single dose 59 mg sildenafil (Viagra)

Objective & Hypothesis:The aim of this study to investigate the effectiveness of single dose 50 mg sildenafil (viagra) in treatment of honeymoon impotence which is a subgroup of psychosocial impotence.

📊

Key Findings & Data:Between March 1999 and February 2000, 14 male patients at the age of 21-35 (average 26.4), who have not been able to have sexual intercourse with their spouse although they were newly married, were included in the study.

💡

Conclusion & Impact:As a conclusion, in treatment of honeymoon impotence, single dose 50 mg sildenafil (viagra) was found effective.

🔬Design:Research Article

📍Scope:2000 Verileri

⚙️Variables:İmpotans · Erkek · Evlilik

Abstract

The aim of this study to investigate the effectiveness of single dose 50 mg sildenafil (viagra) in treatment of honeymoon impotence which is a subgroup of psychosocial impotence. Between March 1999 and February 2000, 14 male patients at the age of 21-35 (average 26.4), who have not been able to have sexual intercourse with their spouse although they were newly married, were included in the study. The history of the patients did not reveal any problems in having an erection. There were no abnormal findings in systemic, genitourinary and neurologic examinations. After having their and their spouses' consent, single dose 50 mg sildenafil (viagra) was given before the sexual intercourse. Twelve of our patients (85.8%), managed to have a sexual intercourse after single dose. In 2 of the patients (14.2%) the treatment failed. In further investigation of these patients, vascular pathologies were detected. As a conclusion, in treatment of honeymoon impotence, single dose 50 mg sildenafil (viagra) was found effective.

Özet

Bu çalışmanın amacı, psikososyal impotansın bir alt grubu olan balayı impotansınm tedavisinde tek doz 50 mg sildenafil'in (viagra) etkinliğini araştırmaktır. Mart-1999 ile Şubat-2000 tarihleri arasında, yaşları 21-35 (ortalama 26.4) olan ve yeni evli olmalarına rağmen eşleriyle ilk cinsel ilişkiyi gerçekleştirememiş olan 14 erkek çalışma kapsamına alınmıştır. Anamnezlerinde evlilik öncesi hiçbirinde ereksiyon problemi yoktu. Sistemik, ürogenital ve nörolojik muayeneleri normaldi Ayrıntılı bilgi verildikten sonra, ilişkiden bir saat önce 50 mg sildenafil (viagra) almaları sağlandı. Hastalarımızın 12'si (%85,8) cinsel ilişkiyi sağladı. İki olguda (%14,2) ilişki sağlanamadı. Bu 2 hastada impotans yönünden ileri tetkikler yapıldı ve vasküler patolojiler saptandı. Sonuç olarak, balayı impotansinin tedavisinde tek doz 50 mg sildenafil (viagra) etkin bulundu.

Keywords

İmpotans Erkek Evlilik Fosfodiesteraz inhibitörleri Impotence Male Marriage Phosphodiesterase Inhibitors

🔖

Cite This Article

GÜL, O., EROĞLU, M., KARABULUT, İ., ÖZOK, U., BAKIRTAŞ, H. (2001). The treatment of honeymoon impotence by single dose 59 mg sildenafil (Viagra). Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 27 - Sayı: 1, 90–92. https://ajindex.com/articles/328585

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Lue TF: Physiology of penile erection and patho-physiology of erectile dysfunction and priapism. In Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds): Campbell’s Urology. WB Saunders Com-pany, Philadelphia, s:1157-1179, 1998 2- Lue TF, Broderick G: Evaluation and nonsurgi-cal management of erectile dysfunction and pri-apism. In Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds): Campbell’s Urology. WB Saun-ders Company, Philadelphia, s: 1181-1214, 1998 3- Anafarta K, Yaman Ö, Hattat H: Erkek Seksü-el Fonksiyon Bozuklukları. In Anafarta K, Göğüş O, Bedük Y, Arıkan N (eds): Temel Üroloji. An-kara, Güneş Kitabevi, s: 1045-1084, 1998 4- Montorsi F, McDermott TED, Morgan R et al: Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 53: 1011-1018, 1999 5- Dinsmore WW, Hodges M, Hargreaves C et al: Sildenafil citrate (viagra) in erectile dysfuncti-on: Near normalization in men with broad-spect-rum erectile dysfunction compared with age-matched healty control subjects. Urology 53:800-805, 1999. 6- Feldman H, Goldstein I, Hadzichristou DG et al: Impotence and its medical and psychosocial correlates: Results of Massachusetts Male Aging Study. J. Urol 151: 54-61, 1994. 7- Marks LS, Duda C, Dorey FJ et al: Treatment of erectile dysfunction with sildenafil. Urology 53: 19-24, 1999. 8- Steers WD: Viagra- after one year. Urology 54: 12-17, 1999. 9- Burnett AL: Oral pharmacotherapy for erectile dysfunction: Current perspectives. Urology 54: 392-400, 1999.